COVID-Inconfidentes - SARS-CoV-2 seroprevalence in two Brazilian urban areas in the fourth quarter 2020: study protocol and initial results
Guardado en:
Autores: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | artículo original |
Estado: | Versión publicada |
Fecha de Publicación: | 2023 |
Descripción: | Objective: To describe study protocol and initial results of research project COVID-Inconfidentes. Method: This paper described the methodological procedures adopted and the prevalence of the SARS-CoV-2 infection in the population. A household survey was conducted between October and December 2020, in two historic cities of Brazil's mining region. Anti-SARS-CoV-2 antibody was detected using the Wondfo® rapid test. The face-to-face interview consisted of administration of a questionnaire containing registration data, sociodemographic and economic variables, living habits, general health condition, mental health, sleep habits, and eating and nutrition. Results: We evaluated 1,762 residents, of which 764 (43.4 %) were in Mariana and 998 (56.6 %) in Ouro Preto. For both cities, 51.9 % of the interviewees were female, with a predominance of the age range 35 to 59 years old (47.2 %). The prevalence of the SARS-CoV-2 infection was 5.5 % in both cities, 6.2 % in Ouro Preto, and 4.7 % in Mariana (p-value > 0.05). Conclusion: The study was effective to estimate the seroprevalence of infection by the virus and its findings will enable further analyses of the health conditions of the population related to social isolation and the risk of infection with SARS-CoV-2. |
País: | Portal de Revistas UCR |
Institución: | Universidad de Costa Rica |
Repositorio: | Portal de Revistas UCR |
Lenguaje: | Inglés |
OAI Identifier: | oai:portal.ucr.ac.cr:article/53127 |
Acceso en línea: | https://revistas.ucr.ac.cr/index.php/psm/article/view/53127 |
Palabra clave: | Coronavirus Infections Pandemics Health Surveys Epidemiology COVID-19 Serological Testing Infecciones por Coronavirus Pandemias Encuestas de Salud Epidemiología Pruebas Serológicas de COVID-19 |